GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide modulate appetite, satiety, and gastric emptying, documented across STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Session 34 measurable pigmentation reduction, more uniform tone, improved radiance
A 57-year-old female, who for five years had been bleeding (stool with residual pink liquid), despite having been under medical control in a public institution, she never underwent a colonoscopy
The choice between berberine and GLP-1 medications depends on your health goals, existing health conditions, and the magnitude of weight loss you seek